Bolt Biotherapeutics, Inc. (BOLT) Financials
BOLT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 40.3 million | 27.7 million |
| March 31, 2026 | 48.0 million | 28.2 million |
| Dec. 31, 2025 | 56.7 million | 30.2 million |
| Sept. 30, 2025 | 65.1 million | 33.0 million |
BOLT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -6.6 million | 552000 |
| March 31, 2026 | -8.0 million | 545000 |
| Dec. 31, 2025 | -7.2 million | 1.0 million |
| Sept. 30, 2025 | -9.8 million | 407000 |
BOLT Net Income
No data available :(
BOLT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 17.6 million | - | 21.6 million |
| March 31, 2026 | 22.9 million | - | 22.3 million |
| Dec. 31, 2025 | 27.5 million | - | 23.0 million |
| Sept. 30, 2025 | 31.9 million | - | 23.6 million |
BOLT Shares Outstanding
BOLT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 13000 | 5.1 million | 2.4 million | - |
| March 31, 2026 | 8.0 million | 4.6 million | 2.8 million | - |
| Dec. 31, 2025 | - | 5.0 million | 3.1 million | - |
| Sept. 30, 2025 | 72000 | 6.5 million | 3.3 million | - |
BOLT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 5000 | - |
| March 31, 2026 | 26000 | 203000 |
| Dec. 31, 2025 | 2.5 million | 255000 |
| Sept. 30, 2025 | 2.2 million | 290000 |
BOLT
Price: $3.30
52 week price:
Earnings Per Share: -15.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 121100
Market Capitalization: 6.2 million